CYP2C9 and Behcet disease: In a prospective study of 52 patients with Behcet’s disease and 96 healthy volunteers, the influence of Behcet’s disease and CYP2C9 genotype on the activity of CYP2C9 (phenotypical determined by measuring the metabolic ratio of losartan) was determine [38].